Deleterious impact of diabetes mellitus on early and mid-term results after stent implantation in left main coronary disease

Nov 16, 2017 by in CARDIOLOGY Comments Off on Deleterious impact of diabetes mellitus on early and mid-term results after stent implantation in left main coronary disease

Background Diabetes mellitus (DM) plays a major role in the development and progression of coronary artery disease and negatively impacts clinical outcome in patients undergoing revascularization. Drug-eluting stents (DES) significantly…

read more

Does reloading clopidogrel for patients with unstable angina who are on chronic clopidogrel therapy and undergoing percutaneous coronary intervention impact outcome?

Nov 16, 2017 by in CARDIOLOGY Comments Off on Does reloading clopidogrel for patients with unstable angina who are on chronic clopidogrel therapy and undergoing percutaneous coronary intervention impact outcome?

Background Previous data suggests that patients presenting with acute coronary syndrome (ACS) who are on chronic clopidogrel have a poor prognosis possibly due to low response to clopidogrel. This study…

read more

Body mass index and bleeding complications after percutaneous coronary intervention in the “bivalirudin era”

Nov 16, 2017 by in CARDIOLOGY Comments Off on Body mass index and bleeding complications after percutaneous coronary intervention in the “bivalirudin era”

Background Little is known about the association between obesity and bleeding complications after percutaneous coronary intervention (PCI). We investigated the impact of body mass index (BMI) on PCI-related bleeding and…

read more

Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy

Nov 16, 2017 by in CARDIOLOGY Comments Off on Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy

Introduction While bivalirudin use in patients undergoing percutaneous coronary intervention (PCI) results in less bleeding compared to unfractionated heparin (UFH), its safety in patients undergoing rotational atherectomy (RA) is unknown….

read more

Angiotensin-converting enzyme therapy and the risk of contrast-induced nephropathy after coronary angiography and percutaneous coronary intervention

Nov 16, 2017 by in CARDIOLOGY Comments Off on Angiotensin-converting enzyme therapy and the risk of contrast-induced nephropathy after coronary angiography and percutaneous coronary intervention

Background The effects of angiotensin-converting enzyme inhibitors (ACEI) on the incidence of post-cardiac catheterization contrast-induced nephropathy (CIN) are not well understood. Some studies suggest that ACEI may contribute to CIN,…

read more

Relationship between platelet reactivity inhibition and major bleeding in patients undergoing percutaneous coronary intervention

Nov 16, 2017 by in CARDIOLOGY Comments Off on Relationship between platelet reactivity inhibition and major bleeding in patients undergoing percutaneous coronary intervention

Background Optimal platelet inhibition is critical to prevent ischemic events following percutaneous coronary intervention (PCI). However, recent studies have suggested that excessive inhibition may favor bleedings. We aimed to investigate…

read more

Adverse outcomes in patients prescribed a proton pump inhibitor following percutaneous coronary intervention with drug-eluting stents

Nov 16, 2017 by in CARDIOLOGY Comments Off on Adverse outcomes in patients prescribed a proton pump inhibitor following percutaneous coronary intervention with drug-eluting stents

Background Recent evidence shows that clopidogrel and proton pump inhibitors (PPI) are metabolized by the same pathway, and patients taking both drugs have higher levels of platelet reactivity and more…

read more

Optimizing the pharmacoinvasive approach to acute ST-segment elevation myocardial infarction: use of half-dose thrombolytic therapy in combination with glycoprotein IIb/IIIa receptor inhibitors compared with full-dose thrombolytic therapy in the setting of routine urgent post-thrombolytic percutaneous coronary intervention

Nov 16, 2017 by in CARDIOLOGY Comments Off on Optimizing the pharmacoinvasive approach to acute ST-segment elevation myocardial infarction: use of half-dose thrombolytic therapy in combination with glycoprotein IIb/IIIa receptor inhibitors compared with full-dose thrombolytic therapy in the setting of routine urgent post-thrombolytic percutaneous coronary intervention

Background Many studies have shown that a pharmacoinvasive strategy of urgent percutaneous coronary intervention following thrombolytic therapy in ST-segment elevation myocardial infarction (STEMI) patients is associated with better outcomes than…

read more

The impact of chronic obstructive pulmonary disease on hemodynamics and outcome in patients with acute myocardial infarction

Nov 16, 2017 by in CARDIOLOGY Comments Off on The impact of chronic obstructive pulmonary disease on hemodynamics and outcome in patients with acute myocardial infarction

Background Patients with chronic obstructive pulmonary disease (COPD) often present with pulmonary hypertension and right ventricular dysfunction. The impact of the reduction in cardiac reserve imposed by COPD on outcome…

read more
Get Clinical Tree app for offline access